Telemedicine-assisted Directly Observed Therapy (DOTS) for Tuberculosis: An Evidence-based Case Report

Authors

  • Valerie Josephine Dirjayanto Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
  • Kieran Pasha Ivan Sini Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
  • Aureilia Calista Zahra Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
  • Pandya Praharsa Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
  • Muhammad Afif Vargas Pramono Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
  • Diantha Soemantri Department of Medical Education, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia

Keywords:

Tuberculosis, telemedicine, directly observed therapy, medication adherence, compliance

Abstract

Background: Tuberculosis is a high-burden infectious disease requiring long-term treatment. Compliance is the key to cure; however, directly observed therapy (DOTS) is not always feasible. Telemedicine use in DOTS offers improved accessibility; however, its effectiveness has not been established. We aimed to investigate the effectiveness of telemedicine-based DOTS on treatment compliance in patients with tuberculosis. Methods: Databases including MEDLINE, Scopus, EMBASE, PubMed, and Cochrane were searched for studies implementing telemedicine-based DOTS until November 2nd, 2023. Studies were appraised for validity, importance, and applicability using the Oxford Centre of Evidence-Based Medicine tool, and the outcomes were graded based on their levels of evidence (LOE). Results: Our search yielded six systematic reviews. Telemedicine-based DOTS yielded favourable effects in improving adherence (LOE: I), treatment completion (LOE: II-III), and cure rates (LOE: II-III). Other outcomes, in terms of bacteriological resolution (LOE: II) and mortality (LOE: IV), were estimated to be non-inferior to those of DOTS. In terms of the telemedicine mode, the VDOTS yielded the highest LOE in improving adherence (LOE: I), followed by short messaging services (LOE: III) and medication monitors (LOE: III), which yielded similar effects. Results for phone reminders were contradictory, with the highest evidence suggesting that it might be ineffective for treatment completion (LOE: I-III) but may increase the cure rate (LOE: III). Conclusion: Telemedicine-based DOTS may improve adherence, treatment completion, and cure rate, and is non-inferior in terms of bacteriological resolution and mortality. Telemedicine-based DOTS can be considered for implementation; however, further high-quality studies in limited-resource settings are needed to strengthen the evidence.

References

Kementerian Kesehatan Republik Indonesia. Laporan Program Penanggulangan Tuberkulosis Tahun 2021 [Internet]. DKI Jakarta: Kementerian Kesehatan Republik Indonesia. 2022 Dec. Available from: https://tbindonesia.or.id/wp-content/uploads/2023/02/Laporan-Tahunan-Program-TBC-2021_Final-20230207.pdf

Yusmaniar Y, Kurniawan AH. Medication adherence to successful Tuberculosis treatment outcome among TB/HIV patients at Prof. Dr. Sulianti Saroso infectious disease hospital. Pharmacology and Clinical Pharmacy Research. 2020 Dec 11;5(3):98-105.

Katiyar SK, Bihari S, Arun S, Rawat T. An analysis of failure of category II DOTS therapy. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive & Social Medicine. 2008 Apr;33(2):129.

Van Dyk L. A review of telehealth service implementation frameworks. International Journal of Environmental Research and Public Health. 2014 Jan;11(2):1279-98.

Mangan JM, Woodruff RS, Winston CA, et al. Recommendations for use of video directly observed therapy during Tuberculosis treatment - United States, 2023. MMWR Morb Mortal Wkly Rep. 2023 Mar 24;72(12):313-6. doi: 10.15585/mmwr.mm7212a4. PMID: 36952279; PMCID: PMC10042619.

Holzman SB, Atre S, Sahasrabudhe T, et al. Use of smartphone-based video directly observed therapy (vDOTS) in Tuberculosis care: Single-arm, prospective feasibility study. JMIR Form Res. 2019 Aug 27;3(3):e13411. doi: 10.2196/13411. PMID: 31456581; PMCID: PMC6734854.

Garfein RS, Liu L, Cuevas-Mota J, et al. Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA. Emerg Infect Dis. 2018 Dec;24(10):1806–15. doi: 10.3201/eid2410.180459.

Advancing patient-centered care in tuberculosis management: a mixed-methods appraisal of video directly observed therapy. Open Forum Infect Dis. 2018 Apr;5(4) doi: 10.1093/ofid/ofy046.

Garfein RS, Collins K, Muñoz F, et al. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study. Int J Tuberc Lung Dis. 2015 Sep;19(9):1057–1064. doi: 10.5588/ijtld.14.0923.

Hoffman JA, Cunningham JR, Suleh AJ, Sundsmo A, Dekker D, Vago F, Munly K, Igonya EK, Hunt-Glassman J. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med. 2010 Jul;39(1):78–80. Doi: 10.1016/j.amepre.2010.02.018.

Nguyen TA, Pham MT, Nguyen TL, Nguyen VN, Pham DC, Nguyen BH, Fox GJ. Video directly observed therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study. Int J Infect Dis. 2017 Dec;65:85–9. doi: 10.1016/j.ijid.2017.09.029

University of Oxford. Oxford Center for Evidence-Based Medicine (OCEBM) critical appraisal tools for systematic reviews. Oxford: Centre for Evidence-Based Medicine; date unknown [cited 2023 Nov 2]. Available from: https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools

Lolong DB, Aryastami NK, Kusrini I, Tobing KL, Tarigan I, Isfandari S et al. Nonadherence to anti-tuberculosis treatment, reasons, and associated factors among pulmonary tuberculosis patients in the communities in Indonesia. PLoS ONE. 2023;18(8):e0287628.

OCEBM Levels of Evidence Working Group. The Oxford levels of evidence 2. Oxford: Oxford Centre for Evidence-Based Medicine. 2011 [cited 2023 Nov 2]. Available from: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence

Truong CB, Tanni KA, Qian J. Video-observed therapy versus directly observed therapy in patients with tuberculosis. Am J Prev Med. 2022 Mar;62(3):450-8.

Wong YJ, Ng KY, Lee SWH. Digital health use in latent tuberculosis infection care: a systematic review. Int J Med Inform. 2022 Mar;159:104687

Alipanah N, Jarlsberg L, Miller C, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018 Jul 3;15(7):e1002595

Ngwatu BK, Nsengiyumva NP, Oxlade O, et al. The impact of digital health technologies on tuberculosis treatment: a systematic review. Eur Respir J. 2018 Jan 11;51(1):1701596.

Ridho A, Alfian SD, van Boven JF, et al. Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: systematic review of randomized controlled trials. J Med Internet Res. 2022 Feb 23;24(2):e33062.

Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infect Dis. 2013 Dec 2;13:566.

Huang GHL, Pawape G, Taune M, et al. Telemedicine in resource-limited settings to optimize care for multidrug-resistant tuberculosis. Frontiers in Public Health. 2019 Aug 13;7(222):1-5.

Holzman SB, Zenilman A, Shah M. Advancing patient-centered care in tuberculosis management: a mixed-methods appraisal of video directly observed therapy. Open Forum Infectious Disease. 2018 Apr;5(4):ofy046.

World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015 Jan 1.

Morrison A, Stauffer ME, Kaufman AS. Defining medication adherence in individual patients. Patient Preference and Adherence. 2015;9:893-7.

Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Medical Journal. 2011 May;26(3):155-9.

Burzynski J, Mangan JM, Lam CK, et al. In-person vs electronic directly observed therapy for tuberculosis treatment adherence. JAMA Network Open. 2022 Jan;5(1):e2144210

Sandgren A, Noordegraaf-Schouten MV, van Kessel F, Stuurman A, Oordt-Speets A, van der Werf MJ. Initiation and completion rates for latent tuberculosis infection treatment: a systematic review. BMC Infectious Diseases. 2016;16(1):1-2.

Siddiqui SB. Evaluating the cost-effectiveness of the tuberculosis video directly observed therapy program at Harris County Public Health & Environmental Services [dissertation]. Texas: The University of Texas Medical Branch; 2016 Aug.

Ridho A, Alfian SD, van Boven JK, et al. Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: systematic review of randomized controlled trials. Journal of Medical Internet Research. 2022;23(2):p.e33062

Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS. Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review. BMC Infectious Diseases. 2013 Dec;13(1):1-6.

World Health Organization. Definitions and reporting framework for tuberculosis–2013 revision: updated December 2014 and January 2020. World Health Organization; 2013.

Truong CB, Tanni KA, Qian J. Video-observed therapy versus directly observed therapy in patients with Tuberculosis. Am J Prev Med. 2022 Mar;62(3):450-8. Doi: 10.1016/j.amepre.2021.10.013. Epub 2021 Dec 13. PMID: 34916094.

Petrosyan A. Number of internet and social media users worldwide as of October 2023 [Internet]. Place unknown: Statistica Website; 2023 Oct 25 [cited 2023 Nov 15]. Available from: https://www.statista.com/statistics/617136/digital-population-worldwide/.

Downloads

Published

2025-10-03

How to Cite

Dirjayanto, V. J., Sini, K. P. I., Zahra, A. C., Praharsa, P., Pramono, M. A. V., & Soemantri, D. (2025). Telemedicine-assisted Directly Observed Therapy (DOTS) for Tuberculosis: An Evidence-based Case Report. Acta Medica Indonesiana, 57(3), 405. Retrieved from http://www.actamedindones.org/index.php/ijim/article/view/2654